Radotinib Decreases Prion Propagation and Prolongs Survival Times in Models of Prion Disease
The conversion of cellular prion protein (PrP<sup>C</sup>) into pathogenic prion isoforms (PrP<sup>Sc</sup>) and the mutation of <i>PRNP</i> are definite causes of prion diseases. Unfortunately, without exception, prion diseases are untreatable and fatal neurodege...
Main Authors: | Yeong-Gon Choi, Byungki Jang, Jeong-Ho Park, Min-Woo Choi, Gong Yeal Lee, Dae Jin Cho, Hong Youp Kim, Hae Kyoung Lim, Won Jae Lee, Eun-Kyoung Choi, Yong-Sun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/15/12241 |
Similar Items
-
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
by: Sook-Kyoung Heo, et al.
Published: (2020-12-01) -
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
by: Suji Baek, et al.
Published: (2022-12-01) -
N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases
by: Hideyuki Hara, et al.
Published: (2020-08-01) -
Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
by: Carlo Scialò, et al.
Published: (2019-03-01) -
Strain-Specific Targeting and Destruction of Cells by Prions
by: Sara M. Simmons, et al.
Published: (2024-01-01)